Biotech Insider:
- RISK ADVISORY
- MARKET SECTOR
- CATEGORY
- Long-term Growth
- Medical/Biotech
- Microcap/Small/Midcap
Biotech Insider provides research on stocks of small biotech companies. The biotech sector offers small investors a unique advantage over large institutional investors and mutual funds, which typically consider the stocks too small to research, monitor or invest in.
PRODUCT STRATEGY: GROWTH
- Biotech Insider looks for small and mid-cap companies that are participating in late phase II and phase III clinical trials. To mitigate risk, we focus primarily on companies that are near the end of a clinical trial cycle.
- However, occasionally we will initiate research and analysis on companies that do not meet this profile if they have great science of a broad-based approach. While these companies may be further from commercialization, they can represent savvy investments for the patient investor.
30-day Money-Back Guarantee
Your Subscription Includes:
- Access to Biotech Insider Portfolio and Positions
- Monthly Research Reports
- Monthly Portfolio Updates
- Trade Alerts
- Education and Investor Resources
- 24/7 Access to Members-Only Portal
- 30-Day 100% Money Back Guarantee
